May 4, 2023/Abu Dhabi

Cleveland Clinic Abu Dhabi’s Fatima bint Mubarak Center introduces new cutting-edge technologies to the UAE

Fatima bint Mubarak Center setting the benchmark in advanced technological expertise in cancer care: Adaptive radiotherapy uses AI, machine learning to maximize therapy while reducing exposure to radiation; chemotherapy robot ensures safe and effortless preparation of hazardous patient-specific doses of medication

Media Downloads

images: 0

video: 0

audio: 0

text: 0

Abu Dhabi, United Arab Emirates: The newly inaugurated Fatima bint Mubarak Center at Cleveland Clinic Abu Dhabi, a Mubadala Health partner, pioneers in cutting-edge and state-of-the-art technologies, bringing world-class cancer care to the UAE. The center’s advanced technological expertise combined with its team of experts, set a new standard of clinical excellence, elevating the quality of cancer screening, diagnostics and treatment available in the region. The center aims to serve as the benchmark for cancer care, providing patients comprehensive access to world-class care close to home.

Cleveland Clinic Abu Dhabi and the Fatima bint Mubarak Center (right)
The AI-aided process reduces treatment time and exposure to radiation compared to traditional treatments.
Radioembolization, TARE-Y90 therapy, is a minimally invasive targeted therapy that uses radioactive particles to destroy cancer cells in the liver.
The chemotherapy robot which leverages an automated compounding process to ensure caregiver and patient safety and prepares patient-specific hazardous doses with ease and accuracy.

The Fatima bint Mubarak Center has introduced Ethos adaptive radiotherapy a cancer treatment technology to the UAE. Using artificial intelligence (A.I.) and machine learning, Ethos allows the radiotherapy medical team to adapt a patient’s treatment plan in real-time, based on daily changes in the patient’s anatomy. Previously considered impossible, the AI-aided process significantly reduces the adaptive treatment time (sessions are approximately 25 to 30 minutes in duration) and exposure to radiation when compared to more traditional treatments. While the machine is suitable for all cancer types, it is currently being primarily used for pelvic, abdominal, bladder and prostate cancers.

The center also offers radioembolization, TARE-Y90 therapy, a minimally invasive targeted therapy that uses radioactive particles to destroy cancer cells in the liver. The procedure involves injecting tiny beads, known as microspheres, into the blood vessels that supply the tumor in the liver with blood. These microspheres emit radiation that targets the tumor cells while sparing healthy liver tissue. This treatment is particularly useful for patients with liver cancer that has spread to other parts of the body, as it can help shrink tumors that may be otherwise inoperable and alleviate symptoms such as pain and fatigue. Radioembolization is a safe and effective treatment option for select patients with liver cancer, offering them an improved quality of life and prolonged survival.

Dr. Stephen Grobmyer, Institute Chair of the Oncology Institute, Cleveland Clinic Abu Dhabi said, “The Fatima bint Mubarak Center is poised to set new standards of clinical excellence in cancer care, fulfilling another milestone in Cleveland Clinic Abu Dhabi’s vision and mission to provide compassionate, complex care and being the best place to receive care. The center has prioritized patient experience, research, innovation, and the most cutting-edge medical technology, including artificial intelligence, transforming the way cancer care is delivered in the region. Patients being treated at the center have access to global healthcare expertise delivered by our team of experienced caregivers. Our fully equipped, premium facility elevates care for cancer through comprehensive world-class screening, and leading-edge diagnostic and treatment options, all conveniently available under one roof, which build on the existing expertise of the Oncology Institute.”

The Fatima bint Mubarak Center is also home to the chemotherapy robot which leverages an automated compounding process to ensure caregiver and patient safety and prepares patient-specific hazardous doses with ease and accuracy. The robot provides numerous benefits, including improved patient and operator safety, greater pharmacist efficiency, and reduced operating costs. Additionally, it boosts nursing confidence, facilitates automated record-keeping, and streamlines inventory management.

The center has also introduced various advanced treatment plans that use the latest and most innovative technologies available, improving the chances of successful outcomes for patients. This includes Edge radiosurgery, another accurate and non-invasive cancer treatment that uses stereotactic radiation to target cancerous cells while sparing healthy ones, making it a highly effective and efficient treatment option. In addition, brachytherapy or internal radiation is a procedure that places radioactive material inside the affected organ. Because this form of therapy allows for the application of high local doses of radiation to specific areas of the body, it leads to fewer side effects than external beam radiation and a shorter overall treatment time.

Dr. Fady Geara, Department Chair, Radiation Oncology, Oncology Institute, Cleveland Clinic Abu Dhabi said, “Introducing technologies such as these make treatment solutions more accurate and effective and helps in minimizing resulting side effects. We will continue to adopt and introduce such innovative approaches that prioritize the highest quality of patient care.”

Modeled on Cleveland Clinic U.S.’ Taussig Cancer Center, one of the top providers of cancer care in the United States, the Fatima bint Mubarak Center brings world-class diagnostic and treatment options and renowned expertise to the UAE, ensuring patients receive the best and most compassionate care – at every step of their care journey, right here in Abu Dhabi.

To know more about the Fatima bint Mubarak Center, visit:

To book an appointment at Cleveland Clinic Abu Dhabi, call 800 8 CCAD (2223), visit ​or download the Cleveland Clinic Abu Dhabi Patient Portal App.

About Cleveland Clinic Abu Dhabi

Cleveland Clinic Abu Dhabi, a part of Mubadala Health, is a multispecialty hospital on Al Maryah Island in Abu Dhabi, UAE. Cleveland Clinic Abu Dhabi is a unique and unparalleled extension of US-based Cleveland Clinic’s model of care, specifically designed to address a range of complex and critical care requirements unique to the Abu Dhabi population.

Cleveland Clinic Abu Dhabi has the following Institutes and Departments: Heart, Vascular & Thoracic, Neurology, Digestive Disease, Eye, Respiratory, Critical Care, Oncology, Transplant, Surgical Subspecialties, Medical Subspecialties, Emergency Medicine, Anesthesiology, Pathology & Laboratory Medicine, Imaging, Quality & Patient Safety, Clinical & Nursing, Research and Education Departments. In all, more than 50 medical and surgical specialties are represented at Cleveland Clinic Abu Dhabi.

The campus is also home to a stand-alone and dedicated cancer center, Fatima bint Mubarak Center. The state-of-the-art, facility provides patients with access to diagnostics and treatment options through world-class facilities across 24 clinical departments that include a range of cancer subspecialities and programs: Blood Cancers, Breast Cancers​​, Endocrine Cancers​​, Gastrointestinal Cancers​, Genitourinary Cancers​, Gynecological Cancers, Head and Neck Cancers​, Neurological Cancers, Thoracic Cancers, Ophthalmological Cancers and Soft Tissue Cancers among others.

Cleveland Clinic Abu Dhabi provides patients in the region direct access to world’s best healthcare providers and Cleveland Clinic’s unique model of care that includes state-of-the-art amenities and world-class service standards, closer to home.

Visit us at

Latest from the Newsroom